Compare GSK & CSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSK | CSX |
|---|---|---|
| Founded | 1715 | 1978 |
| Country | United Kingdom | United States |
| Employees | 66841 | 23000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7B | 94.5B |
| IPO Year | N/A | 1994 |
| Metric | GSK | CSX |
|---|---|---|
| Price | $52.95 | $50.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 20 |
| Target Price | N/A | ★ $43.05 |
| AVG Volume (30 Days) | 4.3M | ★ 13.6M |
| Earning Date | 04-29-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.40% | 1.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | N/A | ★ $10,636,000,000.00 |
| Revenue This Year | $6.99 | $4.58 |
| Revenue Next Year | $4.19 | $4.89 |
| P/E Ratio | ★ $32.75 | $52.27 |
| Revenue Growth | N/A | ★ 17.64 |
| 52 Week Low | $37.71 | $31.80 |
| 52 Week High | $61.70 | $53.60 |
| Indicator | GSK | CSX |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 54.82 |
| Support Level | $49.92 | $44.72 |
| Resistance Level | $53.87 | $53.60 |
| Average True Range (ATR) | 1.06 | 1.20 |
| MACD | -0.00 | -0.18 |
| Stochastic Oscillator | 38.68 | 31.68 |
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Operating in the Eastern United States, Class I railroad CSX generated revenue of nearly $14 billion in 2025. On its more than 21,000 miles of track, CSX hauls shipments of coal (16% of consolidated revenue), chemicals (17%), intermodal containers (16%), automotive cargo (7%), and a diverse mix of other bulk and industrial merchandise.